Novakand Pharma AB (publ) (LARK) - Total Liabilities

Latest as of December 2025: Skr1.24 Million SEK ≈ $133.34K USD

Based on the latest financial reports, Novakand Pharma AB (publ) (LARK) has total liabilities worth Skr1.24 Million SEK (≈ $133.34K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Novakand Pharma AB (publ) equity growth rate to track the company's year-over-year net asset growth rate.

Novakand Pharma AB (publ) - Total Liabilities Trend (2012–2025)

This chart illustrates how Novakand Pharma AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See LARK free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Novakand Pharma AB (publ) Competitors by Total Liabilities

The table below lists competitors of Novakand Pharma AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Karma Energy Limited NSE:KARMAENG	India	Rs95.95 Million
Aptevo Therapeutics Inc NASDAQ:APVO	USA	$8.29 Million
TENET FINTECH GROUP INC. F:P0T	Germany	€29.27 Million
Dermata Therapeutics Inc NASDAQ:DRMA	USA	$1.64 Million
Pagegroup PLC LSE:PAGE	UK	GBX361.10 Million
Hapbee Technologies Inc V:HAPB	Canada	CA$3.86 Million
Askari Metals Ltd AU:AS2	Australia	AU$1.62 Million
Jain Irrigation Systems Limited NSE:JISLDVREQS	India	Rs61.58 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Novakand Pharma AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Novakand Pharma AB (publ) worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novakand Pharma AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novakand Pharma AB (publ) (2012–2025)

The table below shows the annual total liabilities of Novakand Pharma AB (publ) from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr1.24 Million ≈ $133.34K	-71.19%
2024-12-31	Skr4.30 Million ≈ $462.75K	+3.47%
2023-12-31	Skr4.16 Million ≈ $447.22K	-31.86%
2022-12-31	Skr6.10 Million ≈ $656.32K	-23.21%
2021-12-31	Skr7.94 Million ≈ $854.68K	-0.49%
2020-12-31	Skr7.98 Million ≈ $858.87K	-66.06%
2019-12-31	Skr23.51 Million ≈ $2.53 Million	+60.38%
2018-12-31	Skr14.66 Million ≈ $1.58 Million	+801.06%
2017-12-31	Skr1.63 Million ≈ $175.10K	+100.96%
2016-12-31	Skr809.66K ≈ $87.13K	+17.05%
2015-12-31	Skr691.73K ≈ $74.44K	+18.85%
2014-12-31	Skr582.04K ≈ $62.64K	+1320.21%
2013-12-31	Skr40.98K ≈ $4.41K	-86.18%
2012-12-31	Skr296.58K ≈ $31.92K	--

About Novakand Pharma AB (publ)

ST:LARK USA Asset Management

Market Cap

$4.90 Million

Skr45.54 Million SEK

Market Cap Rank

#28666 Global

#5815 in USA

Share Price

Skr2.30

Change (1 day)

+0.00%

52-Week Range

Skr1.84 - Skr2.56

All Time High

Skr2.56